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HIV treatment under control – now  
for sexy prevention?
The South African (SA) government 
launched a ZAR2 billion HIV prevention 
and young women empowerment pro­
gramme, the biggest this country has ever 
seen, at the Pietermaritzburg Showgrounds 
on 24 June – and healthcare workers may 
soon start selling sexual pleasure as a 
prevention tool. The multisector, 3­year 
overseas­funded campaign, to be supple­
mented by an as­yet­undisclosed Treasury 
amount, also aims to reduce teenage 
pregnancies and gender­based violence, 
keep girls in school, and create economic 
opportunities.
Speaking to Izindaba before the launch, 
Dr  Fareed Abdullah, CEO of the South 
African National AIDS Council, embraced 
the ‘pleasure principle’ as part of a multi­
pronged strategy to promote the poorly used 
female condom. Knowledge of Femidoms 
among 15­year­old girls is measured at 
78%, but use at just 7%. ‘It’s a great way to 
think about it because it’s the most effective 
women­controlled HIV prevention method. 
We’d like to increase its attractiveness to both 
sexes,’ he added. Asked why the strategy was 
being considered so belatedly, he responded: 
‘In all honesty, we haven’t embraced it. We 
talk about HIV a lot, but not about sex and 
pleasure and how they drive new infections. 
I’m very open to those making the case and 
who have the expertise.’
SA increased the distribution of condoms 
from 353 million in 2013 to 723 million in 
2015, and of Femidoms from 7.6 million 
in 2013 to 20.7 million last year. While the 
treatment push has reaped rich rewards, 
para doxically contributing to an HIV preva­
lence hike (10 ­ 12% from 2008 to 2012, 
i.e. more people surviving), an increasing 
incidence, especially among younger women, 
is now the big worry. Studies estimate that 
1 700 women between the ages of 18 and 
24  years are being infected with HIV every 
week (latest incidence 2.8%).
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